Performance analysis of Lipocine (LPCN)
Annual Return
Over the past 3 years, LPCN has had an average annual return of -19.72%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, LPCN has had an average annual return of -37.58%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, LPCN has had an average annual return of -28.52%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Oct 22, 2013, LPCN has had an average annual return of -28.90%, underperforming the benchmark SPY, which returned +13.97% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -72.67% | +64.46% | +75% | -58.79% | -59.84% | -27.13% | +253.25% | -70.38% | -62.21% | -6.52% | -71.54% | +145.82% |
| 2014 | 2013 | ||||||||||
| -36.24% | -17.50% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +12.08% | +10.78% | -19.80% | -70.85% | -3.65% | +14.39% | -14.57% | -72.67% | |||||
| 2025 | -11.50% | -28.74% | +3.31% | +4.28% | +2.05% | -6.53% | +2.15% | -10.00% | -1.75% | -7.14% | +29.49% | +133.66% | +64.46% |
| 2024 | +39.63% | -2.18% | +36.61% | -11.11% | +49.63% | +19.16% | -36.91% | -29.41% | +22.22% | +23.48% | -18.10% | +7.49% | +75% |
| 2023 | +33.17% | -14.91% | -29.49% | -18.24% | +4.62% | +8.82% | -1.35% | -20.55% | -24.57% | -14.29% | -5.33% | +15.49% | -58.79% |
| 2022 | +2.93% | +20.59% | +11.38% | -35.62% | -8.05% | -1.23% | -5.87% | -23.08% | -22.41% | -9.11% | +10.02% | -11.56% | -59.84% |
| 2021 | +30.15% | -10.17% | -5.03% | -6.62% | -13.48% | +14.75% | -5.71% | -0.76% | -16.79% | -4.59% | +5.77% | -9.91% | -27.13% |
| 2020 | +14.55% | +12.70% | -3.42% | +15.42% | +64.98% | +37.86% | +22.22% | -3.90% | -4.73% | -14.89% | +33.33% | -15.00% | +253.25% |
| 2019 | +23.85% | +8.07% | +32.76% | -20.35% | -16.85% | +27.45% | -3.08% | +55.56% | -4.42% | -4.27% | -83.46% | -13.48% | -70.38% |
| 2018 | -61.63% | +43.94% | -19.47% | +0.65% | -23.38% | +10.17% | +0.77% | +13.74% | -7.38% | +1.45% | -2.86% | -4.41% | -62.21% |
| 2017 | -1.63% | +9.39% | -1.52% | +8.72% | -13.44% | +9.54% | +26.12% | -25.44% | +5.03% | -11.08% | +1.13% | -3.64% | -6.52% |
Drawdown analysis of Lipocine (LPCN)
The maximum drawdown for the LPCN was -99.39%, occurring on Apr 6, 2026. This drawdown has not yet recovered.
The current LPCN drawdown is -99.30%.
Since Oct 22, 2013 LPCN has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 3 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.39% | Sep 8, 2015 | 2658 | Apr 6, 2026 | Ongoing | Ongoing | Ongoing |
| -60.50% | Oct 22, 2013 | 264 | Nov 7, 2014 | 171 | Jul 16, 2015 | 435 |
| -27.69% | Aug 11, 2015 | 9 | Aug 24, 2015 | 10 | Sep 8, 2015 | 19 |
| -10.96% | Jul 22, 2015 | 6 | Jul 30, 2015 | 7 | Aug 10, 2015 | 13 |